Shionogi Announces In Vitro and Real-World Data Presented at ECCMID 2021 Demonstrating Activity of cefiderocol Against Critical Priority Gram-negative Bacterial Pathogens
In vitro activity of cefiderocol has been demonstrated against the most difficult-to-treat Gram-negative bacteria, including carbapenem-resistant isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus complex, Stenotrophomonas maltophilia,...